Buy TB-500 — USA-Made, COA per Lot
PX1 Research supplies high-purity TB-500 (Thymosin Beta-4 fragment) synthesized strictly for in vitro and preclinical research applications. Designed to meet the demanding analytical standards of academic, biotechnology, and institutional laboratories, every batch undergoes comprehensive HPLC and Mass Spectrometry testing to verify sequence identity and physical purity. Investigators seeking to buy TB-500 can rely on our USA-based manufacturing facilities, transparent lot-specific COAs, and rapid domestic fulfillment.
Quick answer
PX1 Research supplies high-purity TB-500 (Thymosin Beta-4 fragment) synthesized strictly for in vitro and preclinical research applications. Designed to meet the demanding analytical standards of academic, biotechnology, and institutional laboratories, every batch undergoes comprehensive HPLC and Mass Spectrometry testing to verify sequence identity and physical purity. Investigators seeking to buy TB-500 can rely on our USA-based manufacturing facilities, transparent lot-specific COAs, and rapid domestic fulfillment.
Key takeaways
- [TB-500](/research-peptides/tb-500) is a synthetic peptide derivative corresponding to the active region of Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino-acid protein encoded by the TMSB4X gene.
- At the biochemical level, [TB-500](/research-peptides/tb-500) functions primarily through its interaction with globular actin (G-actin).
- Preclinical studies evaluating soft-tissue and muscle-fiber recovery frequently employ [TB-500](/research-peptides/tb-500) to observe its impact on local blood-vessel formation and extracellular matrix organization.
- Selecting a supplier when preparing to buy [TB-500](/research-peptides/tb-500) requires rigorous evaluation of sourcing, synthesis standards, and quality control methodologies.
Overview of TB-500 in Preclinical Research Contexts
TB-500 is a synthetic peptide derivative corresponding to the active region of Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino-acid protein encoded by the TMSB4X gene. In cellular and animal models, this specific sequence—frequently studied as the active hexapeptide or truncated fragment—retains key biological activities associated with actin monomer binding and cell motility. As a targeted regeneration peptide, TB-500 is extensively utilized in research protocols evaluating cellular repair kinetics, microvascular remodeling, and structural protein deposition following acute or chronic tissue injury.
Unlike whole-protein biologics, the synthesized fragment offers enhanced molecular stability and predictable solubility characteristics in standard biochemical buffers. When principal investigators choose to buy TB-500 for laboratory research, obtaining a validated, consistent chemical profile is vital for ensuring experimental reproducibility. Research focusing on cytoskeletal dynamics relies heavily on peptides devoid of truncated sequence contaminants or residual synthesis reagents that could interfere with receptor interaction studies.
Molecular Mechanisms: Actin Binding and Cytoskeletal Dynamics
At the biochemical level, TB-500 functions primarily through its interaction with globular actin (G-actin). Preclinical research demonstrates that the central amino acid motif of Thymosin Beta-4 sequesters G-actin monomers, preventing their spontaneous polymerization into filamentous actin (F-actin) until specific cellular signaling cascades trigger structural remodeling. This dynamic regulation of the actin pool is a fundamental prerequisite for cell migration, lamellipodia formation, and directional cell movement during tissue repair.
In vitro assays indicate that by modulating actin turnover, TB-500 promotes the recruitment and migration of endothelial cells and fibroblasts into disrupted tissue sites. Research models investigating endothelial cell dynamics show that exposure to this fragment increases cell motility without inducing uncontrolled proliferation. To further investigate these pathway dynamics across related molecular targets, researchers often reference our comprehensive research library hub, which details primary signal transduction pathways involved in cell structural dynamics.
Investigational Applications: Soft-Tissue Repair and Vascularization
Preclinical studies evaluating soft-tissue and muscle-fiber recovery frequently employ TB-500 to observe its impact on local blood-vessel formation and extracellular matrix organization. In rodent models of ischemic or mechanical tissue injury, administration of Thymosin Beta-4 fragments has been associated with accelerated capillary sprouting—a process known as angiogenesis—and increased microvascular density. This increased vessel formation aids in restoring oxygen and nutrient flux to regenerating muscle fibers and connective matrices.
Furthermore, tissue flexibility and tensile strength recovery are major endpoints in orthopaedic preclinical trial models. Investigations published in peer-reviewed literature suggest that TB-500 helps modulate collagen deposition, reducing the formation of disorganized fibrotic scar tissue while favoring functional parenchymal or myofibrillar alignment. Researchers analyzing actin-binding proteins utilize TB-500 to dissect the distinct temporal phases of inflammation resolution, cell recruitment, and matrix remodeling in vitro and in vivo.
Quality Assessment: PX1 Research vs. Overseas Supplier Imports
Selecting a supplier when preparing to buy TB-500 requires rigorous evaluation of sourcing, synthesis standards, and quality control methodologies. Overseas suppliers often rely on batch-blended manufacturing practices, high-throughput liquid phase synthesis with inadequate intermediate purification steps, and minimal post-synthesis analytical verification. These imported peptides frequently contain unreacted amino acid sequences, TFA (trifluoroacetic acid) salts in excessive concentrations, and unpredictable endotoxin levels that compromise cell culture viability and introduce confounding variables into animal models.
PX1 Research operates exclusively within USA-based, ISO 17025 accredited analytical environments and GMP-compliant synthesis facilities. Every lot of TB-500 is manufactured using automated solid-phase peptide synthesis (SPPS) under stringent environmental controls. Rather than relying on static or outdated technical datasheets, PX1 provides verifiable, lot-specific Certificates of Analysis (COAs) for every single vial shipped, ensuring absolute sequence accuracy, minimal moisture content, and guaranteed purity levels.
Purity Verification: HPLC, Mass Spectrometry, and Endotoxin Control
Analytical rigor is the cornerstone of reliable scientific inquiry. At PX1 Research, every batch of TB-500 undergoes dual-stage testing prior to lot release. High-Performance Liquid Chromatography (HPLC) is conducted to establish chemical purity, ensuring that the target peptide profile routinely exceeds 99% purity. HPLC analysis detects minor deletion sequences or diastereomers, guaranteeing that experimental data reflects the activity of the pure target compound rather than synthesis byproducts.
In parallel, Electrospray Ionization Mass Spectrometry (ESI-MS) confirms exact molecular weight and sequence identity, ruling out sequence mutations or improper side-chain deprotection. Furthermore, because bacterial endotoxins (lipopolysaccharides) induce severe inflammatory responses in cellular assays and animal models—masking the true biological action of the target peptide—PX1 subjects all research peptides to rigorous Chromogenic LAL (Limulus Amebocyte Lysate) testing. Endotoxin levels are strictly maintained below <0.01 EU/mg, providing a safe and reliable substrate for sensitive biological assays.
Comparative Analysis: TB-500, BPC-157, and GHK-Cu in Preclinical Models
When designing tissue regeneration protocols, investigators frequently compare TB-500 against other prominent research peptides within the repair and remodeling category. A common comparative pairing involves evaluating BPC-157, a synthetic gastric pentadecapeptide known for modulating growth factor expression and nitric oxide pathways, alongside TB-500's primary mechanism of actin-sequestration and cell migration acceleration. While BPC-157 is often studied for its localized gut and tendon healing signaling, TB-500 exhibits broader systemic cell-motility characteristics due to its fundamental role in cytoskeletal organization.
Similarly, GHK-Cu, a naturally occurring copper-binding tripeptide, is heavily investigated for gene expression modulation related to dermal remodeling and antioxidant enzyme upregulation. In contrast, researchers seeking targeted microvascular expansion often pair TB-500 with KPV or other specialized compounds to observe synergistic effects on inflammatory suppression and tissue repair. Reviewing these distinct molecular pathways allows laboratories to construct multi-variable experimental designs tailored to specific cellular targets.
Laboratory Reconstitution and Storage Guidelines
TB-500 is supplied as a lyophilized (freeze-dried) sterile powder to ensure maximum shelf-life and chemical stability during transport and storage. To maintain structural integrity upon arrival, lyophilized vials should be stored at -20°C in a dry, dark environment protected from light. Under these conditions, the un-reconstituted peptide remains stable for extended periods without significant degradation or peptide hydrolysis.
For laboratory use, reconstitution must be performed under aseptic conditions within a laminar flow hood using sterile laboratory-grade solvents. Depending on the planned experimental assay, researchers typically reconstitute the powder using sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile phosphate-buffered saline (PBS, pH 7.4). Care should be taken to gently swirl the vial rather than vortexing aggressively, as mechanical shear stress can disrupt peptide tertiary structure or cause aggregation. Once reconstituted, liquid solutions should be aliquoted into single-use microcentrifuge tubes to prevent repeated freeze-thaw cycles and stored at 2°C to 8°C for short-term experimentation or -80°C for long-term storage.
Domestic Fulfillment, Procurement, and Wholesale Access
Unreliable supply chains and extended customs clearance times present significant challenges to ongoing laboratory project timelines. PX1 Research mitigates these risks by managing all inventory directly from centralized distribution facilities located in California and Arizona. Orders placed before cut-off times Monday through Friday are processed for same-day dispatch, offering reliable tracking and minimized transit duration across North America.
For high-volume academic institutions, contract research organizations (CROs), and corporate research departments requiring ongoing multi-gram quantities, PX1 Research offers flexible procurement channels. Institutional buyers can apply for dedicated accounts through our wholesale program to access tiered volume pricing, custom vial configurations, dedicated lot reservation services, and specialized supply agreement documentation.
Frequently Asked Questions
What is the purity level of PX1 Research's TB-500?
PX1 Research guarantees that every lot of TB-500 achieves a minimum purity of 99% as measured by High-Performance Liquid Chromatography (HPLC). Mass Spectrometry (MS) is also conducted to confirm sequence mass identity.
How is TB-500 shipped, and how should it be stored upon arrival?
TB-500 is shipped in a stable, lyophilized state at ambient temperature via expedited domestic shipping from CA or AZ. Upon receipt, the dry powder should be immediately stored in a freezer at -20°C for optimal long-term stability.
What solvent should be used to reconstitute TB-500 for laboratory research?
Common laboratory solvents for reconstituting lyophilized TB-500 include sterile Bacteriostatic Water or sterile Phosphate-Buffered Saline (PBS, pH 7.4). The choice of solvent depends on the specific in vitro or in vivo experimental assay requirements.
Does PX1 Research provide endotoxin testing documentation?
Yes. Every lot of TB-500 undergoes Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain below <0.01 EU/mg. Endotoxin values are explicitly published on the lot-specific Certificate of Analysis (COA).
How does TB-500 differ from full-length Thymosin Beta-4?
TB-500 represents the active functional fragment of the naturally occurring 43-amino-acid Thymosin Beta-4 protein. The synthetic fragment retains the primary actin-binding sequence responsible for cell migration and angiogenesis while providing improved synthetic purity and stability for research assays.
Can institutional buyers purchase TB-500 in bulk or wholesale quantities?
Yes. PX1 Research offers dedicated support, customized packaging, and volume pricing for academic laboratories, CROs, and industrial clients through our wholesale account portal.
Is TB-500 approved for human administration or clinical use?
No. TB-500 supplied by PX1 Research is strictly sold as a research compound intended exclusively for laboratory, in vitro, and preclinical research applications. It is not for human consumption, therapeutic, or diagnostic use.
How do I access the Certificate of Analysis (COA) for my specific lot?
Each product shipment includes a lot number matching the physical vial label. Researchers can enter this lot number on the PX1 Research website to instantly view and download the full HPLC, MS, and endotoxin analytical reports.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.